The effect of granulocyte-macrophage colony stimulating factor (rGM-CSF) on macrophage function in microbial disease

Medical Oncology

Volumn 13, Issue 3, 1996, Pages 141-147

  Jones, Thomas C ^a  

^a Clinical Research Consultants   (Switzerland)

Author keywords

bacteria; fungi; GM CSF; macrophage; monocyte; virus

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZITHROMYCIN; COLONY STIMULATING FACTOR 1; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR;

BACTERIAL INFECTION; CANCER; HUMAN; MACROPHAGE ACTIVATION; MYCOSIS; PRIORITY JOURNAL; PROTOZOAL INFECTION; REVIEW;

EID: 0030428213     PISSN: 07360118     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02990842     Document Type: Review

References (54)

1. Gasson, J.C. (1991) Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77, 1131-45.
2. Ruef, C. and Coleman, D.L. (1990) Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulness. Rev. Infect. Dis. 12, 41-62.
3. Jones, T.C. (1993) The effects of rhGM-CSF on Macrophage function. Eur. J. Cancer 29A (Suppl. 3), S10-S13.
4. Gerhartz, H.H., Engelhart M., Meusers P., Brittinger, G., Wilmanns, W., Schlimok, G., Mueller, P., Huhn, D., Musch, R., Siegert, W., Gerhartz, D., Hartlapp, J.H., Thiel, E., Huber, C., Peschl, C., Spann, W., Emmerich, B., Schadek, C., Westerhausen, M., Pees, H.W., Radtke, H., Engert, A., Terhardt, E., Schick, H., Binder, T., Fuchs, R., Hasford, J., Brandmaier, R., Stern, A.C., Jones, T.C., Ehrlich, F.J., Stein, H., Panvaresch, M., Tiemann, M. and Lennert, K. (1993) Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas. Blood 82, 2329-39.
5. Nemunaitis, J., Rabinowe, S.N., Singer, J.W., Bierman, P.J., Vose, J.M., Freedman, A.S., Onetto, N., Gillis, S., Oette, D., Gold, M., Buckner, D., Hansen, J.A., Ritz, J., Appelbaum, F.R., Armitage, J.O. and Nadler, L.M. (1991) Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N. Eng. J. Med. 324, 1773-8.
6. Riikonen, P., Saarinen, U.M., Makipernaa, A., Hovi, L., Komulainen, A., Pihkala, J. and Jalanko, H. (1994) Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of fever and neutropenia: a double-blind placebo controlled study in children with malignancy. Ped. J. Inf. Dis. 13, 197-200.
7. Bodey, G.P., Buckley, M., Sathe, Y.S. and Freireich, E.J. (1966) Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Ann. Int. Med. 64, 328-40.
8. Heidenreich, S., Gong-J, H., Schmidt, A., Nain, M. and Gemsa, D. (1989) Macrophage activation by granulocyte-macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2. J. Immunol. 143, 1198-205.
9. Smith, P.D., Lamerson, C.D., Banks, S.M., Saini, S.S., Wahl, L.M., Calderone, R.A. and Wahl, S.M. (1990) Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans. J. Infect. Dis. 161, 999-1005.
10. Smith, P.D., Janoff, E.N. and Wahl, S.M. (1993) Granulocyte-macrophage colony-stimulating factor augmentation of human monocyte effector and accessory cell function. In R. Van Furth (ed.) Hemopoietic Growth Factors and Mononuclear Phagocytes, pp. 79-89. Basel: Karger.
11. Leihl, E., Hildebrandt, J., Lam, C. and Mayer, P. (1994) Prediction of the role of Granulocyte-macrophage colony-stimulating factor in animals and man from in vitro results. Eur. J. Clin. Micr. Inf. Dis. 13 (Suppl 2), S9-S17.
12. Wang, M., Friedman, H. and Djen, I.Y. (1989) Enhancement of human monocyte function against Candida albicans by colony-stimulating factors: 11-3, granulocyte-macrophage colony-stimulating factor, and macrophage-CSF. J. Immunol. 143, 671-7.
13. Chen, G-H., Curtis, J.L., Mody, C.H., Christensen, P.J., Armstrong, L.R. and Toews, G.B. (1994) Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro. J. Immunol. 152, 724-34.
14. Roilides, E., Blake, C., Holmes, A., Pizzo, A. and Walsh, TJ. (1996) Granulocyte-macrophage colony-stimulating factor and interferon-gamma prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against Aspergillus fumigatus hyphae. J. M. V. Mycol. 34, 63-9.
15. Mayer, P., Schutze, E., Lam, C., Krieck, F. and Liehl, E. (1991) Recombinant murine granulocyte-macrophage colony-stimulating factor augments neutrophil recovery and enhances resistance to infection in myelosuppressed mice. J. Inf. Dis. 163, 584-90.
16. Mandujano, J.F., D-Souza, N.B., Nelson, S., Summer, W.R., Beckerman, R.C. and Sellito, J.E. (1995) Granulocyte-macrophage colony-stimulating factor and Pneumocystis carinii pneumonia in mice. Am. J. Respir. Crit. Care Med. 151, 1233-8.
17. Hsu, N., Young, L.S. and Bermudez, L.E. (1995) Response to stimulation with recombinant cytokines and synthesis of cytokines by murine intestinal macrophages infected with Mycobacterium avium complex. Inf. Immunol. 63, 528-33.
18. Bermudez, L.E. (1994) Potential role of cytokines in dessiminated mycobacterial infections. Eur. J. Clin. Micr. Inf. Dis. 13 (Suppl. 2), 29-33.
19. Denis, M. (1991) Involvement of cytokines in determining resistance and acquired immunity in murine tuberculosis. J. Leuc. Biol. 50, 495-501.
20. Weiser, W.Y., van Niel, A., Clark, S.C., David, J.R. and Remold, H.G. (1987) Recombinant human granulocyte-macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages. J. Exp. Med. 166, 1436-46.
21. Ho, J.L., Reed, S.G., Wick, E.A. and Giordano, M. (1990) Granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factors activate intramacrophage killing of Leishmania amazonensis. J. Inf. Dis. 162, 224-30.
22. Reed, S.G. (1993) Macrophage activation and inactivation in protozoal infections. In R. Van Furth (ed.) Hemopoietic Growth Factors and Mononuclear Phagocytes, pp. 90-97. Basle: Karger.
23. Badaro, R., Falcoff, E., Badaro, S.F., Carvalho, E.M., Pedral Sampaio, D., Barral, A., Carvalho, J.S., Arral Netto, M., Brandely, M. and Silva, L. (1990) Treatment of visceral leishmaniasis with penavalent antimony and interferon gamma. N. Eng. J. Med. 322, 16-21.
24. Badaro, R., Nascimento, C., Carvalho, J.S., Badaro, F., Russo, D., Ho, J.L., Reed, S.G., Johnson, W.D. Jr. and Jones, T.C. (1994) Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis. J. Inf. Dis. 170, 413-8.
25. Perno, C-F., Yarchoan, R., Cooney, D.A., Hartman, N.R., Webb, D.S.A., Hao, Z., Mitsuya, H., Johns, D.G. and Broder, S. (1989) Replication of human immunodeficiency virus in monocytes. Granulocyte-macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3′-azido-2′3′-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine. J. Exp. Med. 169, 933-51.
26. Amann, U., Bender, A., Heidenreich, S., Schmidt, A., Nain, M. and Gemsa, D. (1993) Activation of mononuclear phagocytes by granulocyte-macrophage colony-stimulating factor. In R. Van Furth (ed.) Hemopoietic Growth Factors and Mononuclear Phagocytes, pp. 21-28. Basle: Karger.
27. Sinzger, C., Plachter, B., Greffe, A., The, T.H. and Jahn, G. (1996) Tissue macrophages are infected by human cytomegalovirus in vivo. J. Inf. Dis. 173, 240-5.
28. Davison, F.D., Kaczmarski, R.S., Pozniak, A., Mufti, G.J. and Sutherland, S. (1994) Quantification of HIV by PCR in monocytes and lymphocytes in patients receiving antiviral treatment and low dose recombinant human granulocyte-macrophage colony stimulating factor. J. Clin. Path. 47, 855-7.
29. Hardy, D., Spector, B., Polsky, B., Crumpacker, C., van der Horst, C., Holland, G., Freeman, W., Heinemann, M.H., Sharuk, G., Klystra, J. and Chown, M. ACTG 073 Team (1994) Combination of ganciclovir and granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients. Eur. J. Clin. Micr. Inf. Dis. 13 (Suppl. 2), 34-40.
30. Hewitt, R.G., Morse, G.D., Lawrence, W.D., Maliszewski, M.L., Santora, J., Bartos, L., Bonnem, E. and Poiesz, B. (1993) Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex. Antimicrob. Ag. Chemoth. 37, 512-22.
31. Silverstein, S.C., Cao, Ch., Rudin, D., Gao, P. and Neu, H. (1993) Organic anion transporters promote the secretion of anionic antibiotics from cells of the J774 macrophage-like cell line. In R. Van Furth (ed.) Hemopoietic Growth Factors and Mononuclear Phagocytes, pp. 134-9. Basle: Karger.
32. Hiddemann, W., Kiehl, M., Zuhlsdorf, M., Busemann, C., Schleyer, E., Wormann, B. and Buchner, T. (1992) Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia. Semin. Oncol. 19 (Suppl. 4), 31-7.
33. Bermudez, L.E., Martinelli, J., Petrofsky, Kolonoski, P. and Young, L.S. (1994) Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model J. Inf. Dis. 169, 575-80.
34. Laursen, A.L., Rungby, J. and Andersen, P.L. (1995) Decreased activation of the respiratory burst in neutrophils from AIDS patients with previous Pneumocystis carinii pneumonia. J. Inf. Dis. 172, 497-505.
35. Stein, D.K. and Diamond, R.D. (1989) Enhancement of oxidant release and killing of Candida hyphae by neutrophils primed with granulocyte-macrophage colony-stimulating factor. Prog. Abst. 29th Intersci. Conf. Antimicrob. Ag. Chem. Abstr. No. 338.
36. Silberstein, D.S., Fowen, W., Gasson, J.C. et al. (1986) Enhancement of human eosinophil cytotoxidty and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony stimulating factor. J. Immunol. 137, 3290-4.
37. Van den Bosch, G., Preijers, F., Vreugdenhil, A., Hendriks, J., Maas, F. and deWitte, T. (1995) Granulocyte-macrophage colony-stimulating factor (GM-CSF) counteracts the inhibiting effect of monocytes on natural killer (NK) cells. Clin. Exp. Immunol. 101, 515-20.
38. Okamura, S., Tanaka, T., Yamaga, S., Omori, F. and Niho, Y. (1991) The effects of recombinant granulocyte-macrophage colony-stimulating factor on the induction of lymphokine activated killer cells in vitro. Int. J. Immunopharmacol. 13, 587-93.
39. Inaba, K., Schuler, G. and Steinman, R.M. (1993) GM-CSF-A granulocyte/macrophage/dendritic cell stimulating factor. In R. Van Furth (ed.) Hemopoietic Growth Factors and Mononuclear Phagocytes, pp. 187-96. Basle: Karger.
40. Schuler, G. and Romani, N. (1993) Epidermal Langerhans cells as a model for studying the effects of granulocyte-macrophage colony-stimulating factor and other cytokines on the biology of dendritic cells. In R. Van Furth (ed.) Hemopoietic Growth Factors and Mononuclear Phagocytes, pp. 197-204. Basle: Karger.
41. Lin, R., Tarr, P.E. and Jones, T.C. (1995) Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases. Clin. Inf. Dis. 21, 1439-49.
42. Mayordomo, J.I., Rivera, F., Diaz-Puete, N.T. et al. (1995) Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors. J. Natl. Cancer. Inst. 87, 803-8.
43. Riikonen, P. (1995) Recombinant human granulocyte-macrophage colony-stimulating factor in combination with antibiotics in the treatment of febrile neutropenia in children. Stem Cells 13, 201-5.
44. Aviles, A., Rosas, A., Talavera, A. et al. (1994) Use of granulocyte-macrophage colony-stimulating factor in the treatment of infection and severe granulocytopenia. Cancer Res. Ther. Cont. 1, 1-5.
45. Rowe, J.M., Andersen, J.W., Mazzaa, J.J. et al. (1995) A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (>55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490). Blood 85, 457-62.
46. Bodey, G.P., Anaissie, E., Gutterman, J. and Vadhan-Raj, S. (1993) Role of granulocyte-macrophage colony stimulating factor as adjunct therapy for fungal infection in patients with cancer. Clin. Inf. Dis. 17, 705-7.
47. Spielberger, R., Falleroni, M.J., Coene, A.J. and Larson, R.A. (1993) Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for dessiminated infection with Fusarium in a granulocytopenic patient. Clin. Inf. Dis. 16, 528-30.
48. Schoepfer, C., Carla, H., Bezou, M.J. et al. (1995) Malassezia fungemia after bone marrow transplantation. Arch. Pediatr. 2, 245-8.
49. Martino, P., Meloni, G. and Cassone, A. (1990) Candidal endocardidis treated with fluconazole and granulocyte-macrophage colony-stimulating factor. Ann. Int. Med. 112, 966-7.
50. Nemet, D., Labar, B., Bogdanic, V., Mrsic, M., Kovacevicmetelko, J., Radman, I., Jukic, T. and Boban, D. (1993) Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) therapy for delayed engraftment following bone marrow transplantation for leukemia. Periodicum Biologorum 95, 347-54.
51. deWitte, T., Gratwohl, A., van der Lely, N. et al. (1992) Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantation. Blood 79, 1359-65.
52. Fouillard, I., Gorin, N.C., Laporte, J.P.H. et al. (1989) GM-CSF and ganciclovir for cytomegalovirus after autologous bone marrow transplantation. Lancet ii, 1273.
53. Bodey, G.P. (1994) The potential role of granulocyte-macrophage colony-stimulating factor in therapy of fungal infections: a commentary. Eur. J. Clin. Microbiol. Inf. Dis. 13, 363-6.
54. Herbrecht, R. and Cordonnier, C. (1995) Impact of cytokines and growth factors in the antifungal armamentarium. Bailliere Clin. Inf. Dis. 2, 141-155.